When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GH - Guardant: Saving Lives One Blood Test At A Time
Guardant Health Inc.
Summary
Guardant Health derives most of its revenue from FDA-approved liquid-biopsy services as opposed to CLIA-waived laboratory-developed tests "LDT".
As the FDA prepares to extend its regulatory arm over LDT, it might be a good idea to shift your investment exposure to companies with a favorable regulatory position.
Beyond regulatory disruptions, GH's market position is influenced by competing dynamics manifested in commercialization challenges weighed against new product introduction tailwinds.